Skip to content 
VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company utilizes proprietary payloads and genetic code expansion technology to engineer and manufacture homogeneous, stable bioconjugates with defined drug-to-antibody ratios. It also licenses technology platforms to support the development of new therapeutic strategies. The company serves professional clients in the healthcare sector, including those in drug development, biologicals, diagnostics, instrumentation, and partners with research organizations and business partners in the life sciences industry. The company was founded in 2021 and is based in Heidelberg, Germany. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| VRXAW | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| VRXAW | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Veraxa Biotech AG Warrants (VRXAW) share price today is $0.139999
Yes, Indians can buy shares of Veraxa Biotech AG Warrants (VRXAW) on Vested. To buy
Yes, you can purchase fractional shares of Veraxa Biotech AG Warrants (VRXAW) via the Vested app. You can start investing in Veraxa Biotech AG Warrants (VRXAW) with a minimum investment of $1.
You can invest in shares of Veraxa Biotech AG Warrants (VRXAW) via Vested in three simple steps:
The 52-week high price of Veraxa Biotech AG Warrants (VRXAW) is $0.35. The 52-week low price of Veraxa Biotech AG Warrants (VRXAW) is $0.11.
The price-to-earnings (P/E) ratio of Veraxa Biotech AG Warrants (VRXAW) is
The price-to-book (P/B) ratio of Veraxa Biotech AG Warrants (VRXAW) is 0.00
The dividend yield of Veraxa Biotech AG Warrants (VRXAW) is 0.00%
The market capitalization of Veraxa Biotech AG Warrants (VRXAW) is
The stock symbol (or ticker) of Veraxa Biotech AG Warrants is VRXAW
Consider the share price of Veraxa Biotech AG Warrants as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Veraxa Biotech AG Warrants has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Veraxa Biotech AG Warrants shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Veraxa Biotech AG Warrants stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Veraxa Biotech AG Warrants and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Veraxa Biotech AG Warrants stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
